These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 33776370)

  • 21. Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD.
    Selinger CP; Fraser A; Collins P; Gunn M; Chew TS; Kerry G; Patel KV; Roysam M; Bel Kok K; Bancil A; Hall V; Cooney R; Smith L; Steed H; Segal J; Kent A; Limdi J; Sebastian S
    BMJ Open Gastroenterol; 2021 Mar; 8(1):. PubMed ID: 33753426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
    Ng SC; Mak JWY; Hitz L; Chowers Y; Bernstein CN; Silverberg MS
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S791-S797. PubMed ID: 33085973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications.
    Khan N; Mahmud N
    Gastroenterology; 2021 Sep; 161(3):827-836. PubMed ID: 34048782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The gastrointestinal effects of COVID–19 infection during childhood and among the children affected with inflammatory bowel disease].
    Tóbi L; Prehoda B; Balogh A; Dezsőfi-Gottl A; Cseh Á
    Orv Hetil; 2022 Feb; 163(6):214-221. PubMed ID: 35124570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
    Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B
    Intern Med J; 2020 Jul; 50(7):798-804. PubMed ID: 32656985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain.
    Guerra I; Algaba A; Jiménez L; Mar Aller M; Garza D; Bonillo D; Molina Esteban LM; Bermejo F
    Inflamm Bowel Dis; 2021 Jan; 27(1):25-33. PubMed ID: 32830267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
    Burke KE; Kochar B; Allegretti JR; Winter RW; Lochhead P; Khalili H; Colizzo FP; Hamilton MJ; Chan WW; Ananthakrishnan AN
    Inflamm Bowel Dis; 2021 Jan; 27(2):155-161. PubMed ID: 33089863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease.
    Martin-Arranz MD; García-Ramírez L; Hernandez-Perez M; Montero Vega D; Martín-Arranz E; Sánchez-Azofra M; Poza Cordon J; Rueda Garcia JL; Noci Belda J; Verges Martínez-Meco T; Blanco San Miguel P; Suarez Ferrer C
    Sci Rep; 2023 Apr; 13(1):7044. PubMed ID: 37120662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral Immunogenicity After Vaccination Against SARS-CoV-2 Infection in Inflammatory Bowel Disease Patients Under Immunosuppressive Therapy: Should We Prioritize an Additional Booster Injection?
    Macedo Silva V; Lima Capela T; Freitas M; Cúrdia Gonçalves T; Boal Carvalho P; Dias de Castro F; João Moreira M; Cotter J
    Inflamm Bowel Dis; 2023 Feb; 29(2):268-273. PubMed ID: 36099059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases.
    Brenner EJ; Pigneur B; Focht G; Zhang X; Ungaro RC; Colombel JF; Turner D; Kappelman MD; Ruemmele FM
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):394-396.e5. PubMed ID: 33059040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease].
    Teich N; Ludewig C; Schmelz R; Bästlein EC; Geißler S; Nagl S; Walldorf J; Krause T; Maaser C; Mohl W; Wedemeyer HH; Bauer T; Büning C; Grunert P; Hasselblatt P; Hänschen M; Kahl M; Engelke O; Schubert S; Holler B; Streetz K; Arnim UV; Schmidt K; Stallmach A; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Z Gastroenterol; 2021 Nov; 59(11):1189-1196. PubMed ID: 34748206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
    Moum KM; Moum B; Opheim R
    Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study.
    Gilissen LPL; Heinen SGH; Rijpma-Jacobs L; Schoon E; Schreuder RM; Wensing AM; van der Ende-van Loon MCM; Bloemen JG; Stapelbroek JM; Stronkhorst A
    Clin Exp Med; 2022 Aug; 22(3):465-476. PubMed ID: 34542781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing rheumatoid arthritis during COVID-19.
    Roongta R; Ghosh A
    Clin Rheumatol; 2020 Nov; 39(11):3237-3244. PubMed ID: 32892311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic.
    Törüner M; Kalkan İH; Akyüz F; Tezel A; Çelik AF
    Turk J Gastroenterol; 2021 Jun; 32(6):488-492. PubMed ID: 34405814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease.
    De Nicolò A; Cusato J; Bezzio C; Saibeni S; Vernero M; Disabato M; Caviglia GP; Ianniello A; Manca A; D'Avolio A; Ribaldone DG
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Igg seroprevalence in IBD patients treated with biologics: first vs. second pandemic wave in a prospective study.
    Mossa M; Neri B; Montesano L; Salvatori S; Marafini I; Scucchi L; Lolli E; Massoud R; Petruzziello C; Bernardini S; Calabrese E; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3787-3796. PubMed ID: 35647861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence.
    Kumric M; Ticinovic Kurir T; Martinovic D; Zivkovic PM; Bozic J
    World J Gastroenterol; 2021 Jul; 27(25):3748-3761. PubMed ID: 34321841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.